Regulation of Nrf2-mediated phase ii detoxification and anti-oxidant genes

Biomolecules and Therapeutics

Volumn 20, Issue 2, 2012, Pages 144-151

  Keum, Young Sam ^a  

^a Dongguk University   (South Korea)

Author keywords

Antioxidant response element (ARE); Chemoprevention; Kelch like ECH associated protein 1 (Keap1); NF E2 related factor 2 (Nrf2)

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; TRANSCRIPTION FACTOR NRF2; UBIQUITIN PROTEIN LIGASE E3;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CHEMOPROPHYLAXIS; DETOXIFICATION; GENE EXPRESSION REGULATION; HUMAN; INTRACELLULAR SIGNALING; METABOLIC REGULATION; NEDDYLATION; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REVIEW; UBIQUITINATION;

EID: 84862698436     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.2.144     Document Type: Review

References (48)

1. Chen, C., Seth, A. K. and Aplin, A. E. (2006) Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer. Mol. Cancer Res. 4, 695-707.
2. Clements, C. M., McNally, R. S., Conti, B. J., Mak, T. W. and Ting, J. P. (2006) DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. USA. 103, 15091-15096.
3. Cullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W. and Diehl, J. A. (2004) The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell Biol. 24, 8477-8486.
4. Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J. and Diehl, J. A. (2003) Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell Biol. 23, 7198-7209.
5. Furukawa, M., He, Y. J., Borchers, C. and Xiong, Y. (2003) Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. Nat. Cell Biol. 5, 1001-1007.
6. Furukawa, M. and Xiong, Y. (2005) BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell Biol. 25, 162-171.
7. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell. 144, 646-674.
8. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer. Cell. 100, 57-70.
9. He, C. H., Gong, P., Hu, B., Stewart, D., Choi, M. E., Choi, A. M. and Alam, J. (2001) Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J. Biol. Chem. 276, 20858-20865.
10. Higa, L. A. and Zhang, H. (2007) Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy. Cell. Div. 2, 5.
11. Huang, H. C., Nguyen, T. and Pickett, C. B. (2000) Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc. Natl. Acad. Sci. USA. 97, 12475-12480.
12. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M. and Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322.
13. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D. and Yamamoto, M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86.
14. Jain, A. K. and Jaiswal, A. K. (2006) Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 281, 12132-12142.
15. Jeong, W. S., Keum, Y. S., Chen, C., Jain, M. R., Shen, G., Kim, J. H., Li, W. and Kong, A. N. (2005) Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J. Biochem. Mol. Biol. 38, 167-176.
16. Kaelin, W. G. Jr. (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer. 2, 673-682.
17. Kang, M. I., Kobayashi, A., Wakabayashi, N., Kim, S. G. and Yamamoto, M. (2004) Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. USA. 101, 2046-2051.
18. Karapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E. and Vartapetian, A. B. (2005) Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell Biol. 25, 1089-1099.
19. Kensler, T. W., Wakabayashi, N. and Biswal, S. (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89-116.
20. Keum, Y. S., Jeong, W. S. and Kong, A. N. (2004) Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. Mutat. Res. 555, 191-202.
21. Kobayashi, M. and Yamamoto, M. (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox. Signal. 7, 385-394.
22. Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y. S., Ueno, I., Sakamoto, A., Tong, K. I., Kim, M., Nishito, Y., Iemura, S., Natsume, T., Ueno, T., Kominami, E., Motohashi, H., Tanaka, K. and Yamamoto, M. (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 12, 213-223.
23. Li, W., Jain, M. R., Chen, C., Yue, X., Hebbar, V., Zhou, R. and Kong, A. N. (2005) Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J. Biol. Chem. 280, 28430-28438.
24. Li, W. and Kong, A. N. (2009) Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48, 91-104.
25. Li, W., Yu, S. W. and Kong, A. N. (2006) Nrf2 possesses a redox-sensitive nuclear exporting signal in the Neh5 transactivation domain. J. Biol. Chem. 281, 27251-27263.
26. Lippman, S. M. and Hawk, E. T. (2009) Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 69, 5269-5284.
27. Lippman, S. M., Klein, E. A., Goodman, P. J., Lucia, M. S., Thompson, I. M., Ford, L. G., Parnes, H. L., Minasian, L. M., Gaziano, J. M., Hartline, J. A., Parsons, J. K., Bearden, J. D. 3rd, Crawford, E. D., Goodman, G. E., Claudio, J., Winquist, E., Cook, E. D., Karp, D. D., Walther, P., Lieber, M. M., Kristal, A. R., Darke, A. K., Arnold, K. B., Ganz, P. A., Santella, R. M., Albanes, D., Taylor, P. R., Probstfield, J. L., Jagpal, T. J., Crowley, J. J., Meyskens, F. L. Jr, Baker, L. H. and Coltman, C. A. Jr. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 301, 39-51.
28. Liu, J., Furukawa, M., Matsumoto, T. and Xiong, Y. (2002) NEDD8 modification of CUL1 dissociates p120(CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases. Mol. Cell. 10, 1511-1518.
29. Lo, S. C, and Hannink, M. (2006) CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1. Mol. Cell Biol. 26, 1235-1244.
30. McMahon, M., Itoh, K., Yamamoto, M. and Hayes, J. D. (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element- driven gene expression. J. Biol. Chem. 278, 21592-21600.
31. McMahon, M., Thomas, N., Itoh, K., Yamamoto, M. and Hayes, J. D. (2004) Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J. Biol. Chem. 279, 31556-31567.
32. Motohashi, H., O'Connor, T., Katsuoka, F., Engel, J. D. and Yamamoto, M. (2002) Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene. 294, 1-12.
33. Nakayama, K. I. and Nakayama, K. (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer. 6, 369-381.
34. Nguyen, T., Sherratt, P. J., Huang, H. C., Yang, C. S. and Pickett, C. B. (2003) Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 278, 4536-4541.
35. Nioi, P., Nguyen, T., Sherratt, P. J. and Pickett, C. B. (2005) The carboxy- terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol. Cell Biol. 25, 10895-10906.
36. Ohtsubo, T., Kamada, S., Mikami, T., Murakami, H. and Tsujimoto, Y. (1999) Identification of NRF2, a member of the NF-E2 family of transcription factors, as a substrate for caspase-3(-like) proteases. Cell Death Differ. 6, 865-872.
37. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., Barnhart, S. and Hammar, S. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334, 1150-1155.
38. Petroski, M. D. and Deshaies, R. J. (2005) Function and regulation of cullin-RING ubiquitin ligases. Nature Reviews Molecular Cell Biology 6, 9-20.
39. Pickart, C. M. (2004) Back to the future with ubiquitin. Cell. 116, 181-190.
40. Sharpless, N. E. and Depinho, R. A. (2006) The mighty mouse: genetically engineered mouse models in cancer drug development. Nat. Rev. Drug Discov. 5, 741-754.
41. Sumara, I., Maerki, S. and Peter, M. (2008) E3 ubiquitin ligases and mitosis: embracing the complexity. Trends Cell Biol. 18, 84-94.
42. Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H., Tashiro, S., Takahashi, S., Shibahara, S., Alam, J., Taketo, M. M., Yamamoto, M. and Igarashi, K. (2002) Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO. J. 21, 5216-5224.
43. Sykiotis, G. P. and Bohmann, D. (2010) Stress-activated cap'n'collar transcription factors in aging and human disease. Sci. Signal. 3 (112), re3.
44. Tong, K. I., Kobayashi, A., Katsuoka, F. and Yamamoto, M. (2006) Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 387, 1311-1320.
45. Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S. and Yamamoto, M. (2007) Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol. Cell Biol. 27, 7511-7521.
46. Vogelstein, B. and Kinzler, K. W. (2004) Cancer genes and the pathways they control. Nat. Med. 10, 789-799.
47. Zhang, D. D. (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38, 769-789.
48. Zhang, D. D. and Hannink, M. (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell Biol. 23, 8137-8151.